Position | Company | Period |
---|
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-01-10 | 2024-01-09 |
Fate Therapeutics Inc
(FATE)
|
S Sale |
11,271
-6.7%
4.3849,367 USD |
11,271 -6.7% | 4.38 | 49,367 USD | |
2023-01-11 | 2023-01-10 |
Fate Therapeutics Inc
(FATE)
|
S Sale |
10,917
-6.1%
5.2457,205 USD |
10,917 -6.1% | 5.24 | 57,205 USD | |
2022-01-13 | 2022-01-11 |
Fate Therapeutics Inc
(FATE)
|
S Sale |
418
-0.3%
49.1220,532 USD |
418 -0.3% | 49.12 | 20,532 USD | |
2022-01-13 | 2022-01-11 |
Fate Therapeutics Inc
(FATE)
|
S Sale |
4,152
-2.7%
48.44201,123 USD |
4,152 -2.7% | 48.44 | 201,123 USD | |
2022-01-12 | 2022-01-10 |
Fate Therapeutics Inc
(FATE)
|
S Sale |
351
-0.2%
47.1716,557 USD |
351 -0.2% | 47.17 | 16,557 USD | |
2022-01-12 | 2022-01-10 |
Fate Therapeutics Inc
(FATE)
|
S Sale |
5,245
-3.3%
46.33243,001 USD |
5,245 -3.3% | 46.33 | 243,001 USD | |
2021-12-14 | 2021-12-13 |
Fate Therapeutics Inc
(FATE)
|
PS Planned sale |
1,600
-1.0%
49.2778,832 USD |
1,600 -1.0% | 49.27 | 78,832 USD | |
2021-12-14 | 2021-12-13 |
Fate Therapeutics Inc
(FATE)
|
PS Planned sale |
7,718
-4.6%
48.75376,253 USD |
7,718 -4.6% | 48.75 | 376,253 USD | |
2021-12-14 | 2021-12-13 |
Fate Therapeutics Inc
(FATE)
|
PS Planned sale |
6,564
-3.8%
47.61312,512 USD |
6,564 -3.8% | 47.61 | 312,512 USD | |
2021-12-14 | 2021-12-13 |
Fate Therapeutics Inc
(FATE)
|
PS Planned sale |
7,018
-3.9%
46.72327,881 USD |
7,018 -3.9% | 46.72 | 327,881 USD | |
2021-12-14 | 2021-12-13 |
Fate Therapeutics Inc
(FATE)
|
PS Planned sale |
2,100
-1.2%
45.6895,928 USD |
2,100 -1.2% | 45.68 | 95,928 USD | |
2021-09-14 | 2021-09-13 |
Fate Therapeutics Inc
(FATE)
|
PS Planned sale |
800
-0.8%
67.4653,965 USD |
800 -0.8% | 67.46 | 53,965 USD | |
2021-09-14 | 2021-09-13 |
Fate Therapeutics Inc
(FATE)
|
PS Planned sale |
8,391
-8.0%
66.84560,879 USD |
8,391 -8.0% | 66.84 | 560,879 USD | |
2021-09-14 | 2021-09-13 |
Fate Therapeutics Inc
(FATE)
|
PS Planned sale |
15,809
-13.1%
65.941,042,414 USD |
15,809 -13.1% | 65.94 | 1,042,414 USD | |
2021-06-16 | 2021-06-14 |
Fate Therapeutics Inc
(FATE)
|
PS Planned sale |
400
-0.4%
90.7636,303 USD |
400 -0.4% | 90.76 | 36,303 USD | |
2021-06-16 | 2021-06-14 |
Fate Therapeutics Inc
(FATE)
|
PS Planned sale |
8,220
-7.9%
89.68737,155 USD |
8,220 -7.9% | 89.68 | 737,155 USD | |
2021-06-16 | 2021-06-14 |
Fate Therapeutics Inc
(FATE)
|
PS Planned sale |
16,380
-13.6%
89.111,459,587 USD |
16,380 -13.6% | 89.11 | 1,459,587 USD | |
2021-03-16 | 2021-03-15 |
Fate Therapeutics Inc
(FATE)
|
PS Planned sale |
1,018
-1.1%
94.5996,297 USD |
1,018 -1.1% | 94.59 | 96,297 USD | |
2021-03-16 | 2021-03-15 |
Fate Therapeutics Inc
(FATE)
|
PS Planned sale |
3,205
-3.2%
93.75300,461 USD |
3,205 -3.2% | 93.75 | 300,461 USD | |
2021-03-16 | 2021-03-15 |
Fate Therapeutics Inc
(FATE)
|
PS Planned sale |
8,404
-7.8%
92.64778,578 USD |
8,404 -7.8% | 92.64 | 778,578 USD | |
2021-03-16 | 2021-03-15 |
Fate Therapeutics Inc
(FATE)
|
PS Planned sale |
8,416
-7.2%
91.94773,782 USD |
8,416 -7.2% | 91.94 | 773,782 USD | |
2021-03-16 | 2021-03-15 |
Fate Therapeutics Inc
(FATE)
|
PS Planned sale |
3,957
-3.3%
90.89359,654 USD |
3,957 -3.3% | 90.89 | 359,654 USD | |
2021-01-12 | 2021-01-11 |
Fate Therapeutics Inc
(FATE)
|
S Sale |
871
-1.1%
109.6595,509 USD |
871 -1.1% | 109.65 | 95,509 USD | |
2021-01-12 | 2021-01-11 |
Fate Therapeutics Inc
(FATE)
|
S Sale |
1,051
-1.3%
110.76116,407 USD |
1,051 -1.3% | 110.76 | 116,407 USD | |
2021-01-12 | 2021-01-11 |
Fate Therapeutics Inc
(FATE)
|
S Sale |
1,332
-1.6%
111.62148,673 USD |
1,332 -1.6% | 111.62 | 148,673 USD | |
2021-01-12 | 2021-01-08 |
Fate Therapeutics Inc
(FATE)
|
S Sale |
151
-0.2%
114.7617,328 USD |
151 -0.2% | 114.76 | 17,328 USD | |
2021-01-12 | 2021-01-08 |
Fate Therapeutics Inc
(FATE)
|
S Sale |
872
-1.1%
115.80100,977 USD |
872 -1.1% | 115.80 | 100,977 USD | |
2021-01-12 | 2021-01-08 |
Fate Therapeutics Inc
(FATE)
|
S Sale |
2,451
-2.9%
117.15287,144 USD |
2,451 -2.9% | 117.15 | 287,144 USD | |
2021-01-12 | 2021-01-08 |
Fate Therapeutics Inc
(FATE)
|
S Sale |
2,756
-3.2%
117.60324,103 USD |
2,756 -3.2% | 117.60 | 324,103 USD | |
2020-12-15 | 2020-12-14 |
Fate Therapeutics Inc
(FATE)
|
PS Planned sale |
100
-0.1%
102.7510,275 USD |
100 -0.1% | 102.75 | 10,275 USD | |
2020-12-15 | 2020-12-14 |
Fate Therapeutics Inc
(FATE)
|
PS Planned sale |
1,006
-1.1%
102.06102,675 USD |
1,006 -1.1% | 102.06 | 102,675 USD | |
2020-12-15 | 2020-12-14 |
Fate Therapeutics Inc
(FATE)
|
PS Planned sale |
400
-0.5%
100.9740,388 USD |
400 -0.5% | 100.97 | 40,388 USD | |
2020-12-15 | 2020-12-14 |
Fate Therapeutics Inc
(FATE)
|
PS Planned sale |
3,822
-4.1%
99.77381,315 USD |
3,822 -4.1% | 99.77 | 381,315 USD | |
2020-12-15 | 2020-12-14 |
Fate Therapeutics Inc
(FATE)
|
PS Planned sale |
3,148
-3.3%
98.80311,013 USD |
3,148 -3.3% | 98.80 | 311,013 USD | |
2020-12-15 | 2020-12-14 |
Fate Therapeutics Inc
(FATE)
|
PS Planned sale |
2,946
-3.0%
97.70287,812 USD |
2,946 -3.0% | 97.70 | 287,812 USD | |
2020-12-15 | 2020-12-14 |
Fate Therapeutics Inc
(FATE)
|
PS Planned sale |
11,765
-10.7%
96.651,137,141 USD |
11,765 -10.7% | 96.65 | 1,137,141 USD | |
2020-12-15 | 2020-12-14 |
Fate Therapeutics Inc
(FATE)
|
PS Planned sale |
1,813
-1.6%
95.89173,857 USD |
1,813 -1.6% | 95.89 | 173,857 USD | |
2020-09-16 | 2020-09-14 |
Fate Therapeutics Inc
(FATE)
|
PS Planned sale |
600
-0.7%
37.4922,494 USD |
600 -0.7% | 37.49 | 22,494 USD | |
2020-09-16 | 2020-09-14 |
Fate Therapeutics Inc
(FATE)
|
PS Planned sale |
7,016
-7.4%
36.93259,085 USD |
7,016 -7.4% | 36.93 | 259,085 USD | |
2020-09-16 | 2020-09-14 |
Fate Therapeutics Inc
(FATE)
|
PS Planned sale |
16,784
-15.0%
36.03604,654 USD |
16,784 -15.0% | 36.03 | 604,654 USD | |
2020-09-16 | 2020-09-14 |
Fate Therapeutics Inc
(FATE)
|
PS Planned sale |
600
-0.5%
34.6520,792 USD |
600 -0.5% | 34.65 | 20,792 USD | |
2020-01-10 | 2020-01-08 |
Fate Therapeutics Inc
(FATE)
|
S Sale |
5,700
-6.2%
20.69117,947 USD |
5,700 -6.2% | 20.69 | 117,947 USD | |
2019-10-16 | 2019-10-15 |
Fate Therapeutics Inc
(FATE)
|
S Sale |
6,200
-8.5%
14.1887,891 USD |
6,200 -8.5% | 14.18 | 87,891 USD |